What is he best known for?
The fields of study he is best known for:
The scientist’s investigation covers issues in Genetics, Computational biology, Gene, Saccharomyces cerevisiae and Cell biology.
His study in Interactome, Epistasis, CRISPR, Regulation of gene expression and Gene interaction falls within the category of Genetics.
His Computational biology study combines topics in areas such as Proteome, Bioinformatics, Synthetic genetic array, Protein–protein interaction and Gene regulatory network.
His studies deal with areas such as Viral replication and Function as well as Gene.
The concepts of his Saccharomyces cerevisiae study are interwoven with issues in Probabilistic logic and Phosphorylation.
His biological study spans a wide range of topics, including Molecular biology and Gene expression.
His most cited work include:
- Global landscape of protein complexes in the yeast Saccharomyces cerevisiae (2539 citations)
- Global Mapping of the Yeast Genetic Interaction Network (1827 citations)
- A SARS-CoV-2 protein interaction map reveals targets for drug repurposing. (1317 citations)
What are the main themes of his work throughout his whole career to date?
Nevan J. Krogan focuses on Cell biology, Genetics, Gene, Computational biology and Virology.
His Cell biology research is multidisciplinary, incorporating elements of Transcription, Ubiquitin, Ubiquitin ligase and Proteomics.
In his study, Molecular biology is strongly linked to RNA polymerase II, which falls under the umbrella field of Transcription.
Saccharomyces cerevisiae, Gene regulatory network, Chromatin, Epistasis and Mutant are among the areas of Genetics where Nevan J. Krogan concentrates his study.
His studies in Computational biology integrate themes in fields like Phenotype, Bioinformatics, Protein–protein interaction and Interactome.
His study in Virology is interdisciplinary in nature, drawing from both RNA interference and Gene knockdown.
He most often published in these fields:
- Cell biology (63.34%)
- Genetics (54.39%)
- Gene (37.01%)
What were the highlights of his more recent work (between 2019-2021)?
- Cell biology (63.34%)
- Computational biology (35.80%)
- Phosphorylation (15.32%)
In recent papers he was focusing on the following fields of study:
His primary areas of investigation include Cell biology, Computational biology, Phosphorylation, Kinase and Virology.
His Cell biology research is multidisciplinary, incorporating perspectives in Proteome, Ubiquitin, Ubiquitin ligase and Proteomics.
His Computational biology research incorporates elements of Druggability, Mutant, Gene, Virus and Disease.
His Gene study deals with the bigger picture of Genetics.
His work deals with themes such as Mutation, Uridine diphosphate, Nucleoprotein and Host protein, which intersect with Phosphorylation.
His research integrates issues of Coronavirus and Severe acute respiratory syndrome coronavirus 2 in his study of Virology.
Between 2019 and 2021, his most popular works were:
- A SARS-CoV-2 protein interaction map reveals targets for drug repurposing. (1317 citations)
- The Global Phosphorylation Landscape of SARS-CoV-2 Infection. (231 citations)
- Comparative host-coronavirus protein interaction networks reveal pan-viral disease mechanisms. (87 citations)
In his most recent research, the most cited papers focused on:
Nevan J. Krogan mainly investigates Cell biology, Virology, Coronavirus, Virus and Viral entry.
His Cell biology research focuses on subjects like Interferon, which are linked to Importin, Nuclear pore and Karyopherin.
Nevan J. Krogan has included themes like Kinase, MAPK/ERK pathway, p38 mitogen-activated protein kinases and Phosphoproteomics in his Virology study.
The Viral entry study which covers Function that intersects with Antibody.
His research on Lineage concerns the broader Gene.
His work in Phenotype tackles topics such as Computational biology which are related to areas like In vivo.
This overview was generated by a machine learning system which analysed the scientist’s
body of work. If you have any feedback, you can
contact us
here.
